Key result
Impaired stroke volume index (<35 ml/m2) in acute decompensated heart failure was associated with significantly worse survival compared to preserved SVi (HR 5.5; 95% CI 2.1-14.3; p=0.04).
Why the study?
Risk stratification of patients hospitalized for ADHF based on absolute LVEF at presentation is unexplored, and its prognostic significance had not been tested against SVi.
Does stroke volume indexed (SVi) predict cardiovascular events better than left ventricular ejection fraction (LVEF) in patients hospitalized for acute decompensated heart failure?
Cohort (n=85)
Does stroke volume indexed (SVi) predict cardiovascular events better than left ventricular ejection fraction (LVEF) in patients hospitalized for acute decompensated heart failure?
Hazard Ratio: 5.5 (95% CI 2.1–14.3)
p-value: p=0.04
In patients with acute decompensated heart failure, stroke volume index at admission is a stronger predictor of cardiovascular events and survival than left ventricular ejection fraction.
Background Heart failure (HF) patients are categorized according to left ventricular ejection fraction (LVEF), being such index both easily feasible and prognostic. However, the risk stratification of patients hospitalized for acute decompensated heart failure (ADHF) according to the absolute value of LVEF at presentation is unexplored and its prognostic significance has not been tested against stroke volume indexed (SVi). Purpose To examine the prognostic impact of SVi versus LVEF in patients hospitalized for ADHF (wet and warm phenotype). Methods Eighty-five ADHF patients (mean age 75.6±10.4 years, 59% males) were prospectively enrolled within 24–48 hours from admission to the emergency department. In the acute phase all patients underwent a complete transthoracic echocardiography (TTE) and lung ultrasonography (LUS) associated with blood sample and a thorough clinical examination. Patients were then stratified into two groups according to the presence or the absence of a preserved SVi at admission (SVi ≥35 ml/m2). Results During a median follow-up (FU) time of 12 months (IQR months 8–15 months) we observed a CV event rate of 28.2%. During the FU period 14 patients (16.5%) were re-hospitalized for ADHF, 7 patients died for CV reason (8.2%), 1 patient underwent mitral valve replacement for severe chronic mitral regurgitation, 1 patient was re-hospitalized for cardiac resynchronization therapy and 1 subject was re-hospitalized for acute coronary syndrome. Interestingly, patients that had a preserved TTE-derived SVi at admission (SVi ≥35 ml/m2) exhibited a significantly higher survival, when compared to subjects that showed an impairment of cardiac output at rest (SVi <35 ml/m2) (log-rank: HR 5.5 CI 95% 2.1–14.3; p=0.04) (Figure 1). On the other hand, LVEF was not independently associated with the endpoint and HFrEF, HFmrEF and HFpEF patients showed a comparable median survival (Figure 2). Conclusions Although the categorization of LVEF in CHF patients bears a pivotal classificatory and prognostic role, its assessment in ADHF, may lack of prognostic value especially when compared to SVi which represents a better parameter to define high-risk subjects who benefit from closer monitoring. Funding Acknowledgement Type of funding sources: None.
No takes yet. Share an insight, caveat, or question.
Barki et al. (2021) conducted a cohort in Acute decompensated heart failure (ADHF) (n=85). Impaired stroke volume index (SVi <35 ml/m2) vs. Preserved stroke volume index (SVi ≥35 ml/m2) was evaluated on Cardiovascular events (composite of CV death, re-hospitalization for ADHF, ACS, or CRT, and valve replacement) (HR 5.5, 95% CI 2.1-14.3, p=0.04). Impaired stroke volume index (<35 ml/m2) in acute decompensated heart failure was associated with significantly worse survival compared to preserved SVi (HR 5.5; 95% CI 2.1-14.3; p=0.04).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: